Firebrick Pharma Ltd (ASX:FRE) has debuted on the Australian stock exchange today.
Following an IPO at $0.20/share raising $7 million, shares in the pharmaceutical developer skyrocketed 165% to close its debut session at $0.53/share.
An increase in listing price is a vote of confidence from the market about the future prospects of the company.
A decrease in the listing price can be interpreted in a number of ways, including whether the IPO was accurately priced.